AGM/EGMApr 29, 2026, 04:48 PM
SLN Sets 2026 Annual General Meeting for June 16
AI Summary
Silence Therapeutics plc announced its 2026 Annual General Meeting (AGM) will be held on Tuesday, June 16, 2026, as a hybrid meeting in Hoboken, NJ, and electronically. Shareholders will vote on nine ordinary resolutions, including the re-appointment of two directors, the ratification and re-appointment of PricewaterhouseCoopers LLP as auditors, and the approval of the 2025 U.K. annual accounts and directors' remuneration report. The board recommends voting for all proposed resolutions.
Key Highlights
- 2026 Annual General Meeting (AGM) scheduled for June 16, 2026.
- AGM to be held as a hybrid meeting in Hoboken, NJ, and electronically.
- Shareholders to vote on re-appointment of Rhonda Hellums and James Ede-Golightly as directors.
- Ratification of PricewaterhouseCoopers LLP as U.S. independent auditor for 2026.
- Re-appointment of PricewaterhouseCoopers LLP as U.K. statutory auditors.
- Approval of 2025 U.K. statutory annual accounts and reports.
- Advisory vote on 2025 executive compensation and directors' remuneration report.
- Ordinary shareholder record date is June 12, 2026; ADS holder record date is April 27, 2026.
Price Impact
More from SLN